Up next

Autoplay

Upfront Immunotherapy for Metastatic Kidney Cancer

0 Views • 06/26/23
Share
Embed
administrator
administrator
Subscribers
0

Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay